EXPRESSION OF PSTAT5 IN CD34+/CD38-STEM CELLS IN JAK2 V617F+MYELOPROLIFERATIVE NEOPLASMS (MPN)

被引：0
|
作者：
Hadzijusufovic, E. [1 ]
Schur, F. [2 ]
Cerny-Reiterer, S. [1 ]
Pecnard, E. [3 ]
Gouilleux, F. [3 ]
Valent, P. [1 ]
机构：
[1] Ludwig Boltzmann Cluster Oncol, Vienna, Austria
[2] Med Univ Vienna, Vienna, Austria
[3] UMR7292 Genet Immunotherapie Chim & Canc, Tours, France
来源：
HAEMATOLOGICA | 2012年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0115
引用
收藏
页码：45 / 45
页数：1
相关论文
共 50 条
  • [1] pSTAT3/pSTAT5 Signaling Patterns in JAK2 V617F versus CALR Mutated Myeloproliferative Neoplasms
    Schneider, K. C.
    Cook, J. R.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 769 - 770
  • [2] Expression of CD markers in JAK2(V617F) positive myeloproliferative neoplasms: Prognostic significance
    Shahrabi, Saeid
    Ehsanpour, Ali
    Heidary, Somayyeh
    Shahjahani, Mohammad
    Behzad, Masumeh Maleki
    [J]. ONCOLOGY REVIEWS, 2018, 12 (02) : 109 - 120
  • [3] ACTIVATED STAT5 AS NOVEL STEM TARGET IN JAK2 V617F POSITIVE MYELOPROLIFERATIVE NEOPLASMS (MPN)
    Hadzijusufovic, E.
    Keller, A.
    Schur, F.
    Cerny-Reiterer, S.
    Hoermann, G.
    Mayerhofer, M.
    Boudot, C.
    Gouilleux, F.
    Muellauer, L.
    Moriggl, R.
    Valent, P.
    [J]. HAEMATOLOGICA, 2015, 100 : 524 - 525
  • [4] Low Level JAK2 V617F Is Significant in Confirming a Clinical Suspicion of Myeloproliferative Neoplasms (MPN)
    Chevarie-Davis, M.
    Riley, A. C.
    Lopategui, J.
    [J]. LABORATORY INVESTIGATION, 2014, 94 : 342A - 342A
  • [5] A Prolonged Low Level JAK2 V617F Is Significant In Clinically Suspicious Myeloproliferative Neoplasms (MPN)
    Vail, E.
    Chevarie-Davis, M.
    Riley, C.
    Lopategui, J.
    [J]. JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 957 - 958
  • [6] MOLECULAR STUDY OF CALR GENE: MYELOPROLIFERATIVE NEOPLASMS (MPN) WITH NEGATIVE PHILADELPHIA AND JAK2/V617F
    Culurgioni, F.
    Musiu, C.
    Uda, S.
    Benziane, A.
    Pettinau, M.
    Usala, E.
    Cabras, M. G.
    [J]. HAEMATOLOGICA, 2017, 102 : 167 - 168
  • [7] Low Level JAK2 V617F Is Significant in Confirming a Clinical Suspicion of Myeloproliferative Neoplasms (MPN)
    Chevarie-Davis, M.
    Riley, A. C.
    Lopategui, J.
    [J]. MODERN PATHOLOGY, 2014, 27 : 342A - 342A
  • [8] Differential NOD/SCID mouse engraftment of peripheral blood CD34+ cells and JAK2V617F clones from patients with myeloproliferative neoplasms
    Fung, Tsz-Kan
    Cheung, Alice M. S.
    Kwong, Yok-Lam
    Liang, Raymond
    Leung, Anskar Y. H.
    [J]. LEUKEMIA RESEARCH, 2010, 34 (10) : 1390 - 1394
  • [9] Effect of hypoxia on HIF-1a and NOS3 expressions in CD34+ cells of JAK2V617F-positive myeloproliferative neoplasms
    Soroglu, Can Veysel
    Uslu-Bicak, Ildeniz
    Toprak, Selin Fulya
    Yavuz, Akif Selim
    Solzer, Selcuk
    [J]. ADVANCES IN MEDICAL SCIENCES, 2023, 68 (02): : 169 - 175
  • [10] Relation between JAK2 (V617F) mutation status, granulocyte activation, and constitutive mobilization of CD34+ cells into peripheral blood in myeloproliferative disorders
    Passamonti, F
    Rumi, E
    Pietra, D
    Della Porta, MG
    Boveri, E
    Pascutto, C
    Vanelli, L
    Arcaini, L
    Burcheri, S
    Malcovati, L
    Lazzarino, M
    Cazzola, M
    [J]. BLOOD, 2006, 107 (09) : 3676 - 3682
12345